nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2D6—breast cancer	0.176	0.538	CbGaD
Halofantrine—CYP3A4—breast cancer	0.151	0.462	CbGaD
Halofantrine—CYP3A5—Lapatinib—breast cancer	0.0367	0.0772	CbGbCtD
Halofantrine—CYP2C8—Lapatinib—breast cancer	0.0353	0.0742	CbGbCtD
Halofantrine—CYP3A4—Exemestane—breast cancer	0.0283	0.0596	CbGbCtD
Halofantrine—CYP2C8—Raloxifene—breast cancer	0.0267	0.0563	CbGbCtD
Halofantrine—CYP2D6—Idarubicin—breast cancer	0.0255	0.0538	CbGbCtD
Halofantrine—CYP3A4—Letrozole—breast cancer	0.024	0.0506	CbGbCtD
Halofantrine—CYP3A4—Anastrozole—breast cancer	0.0214	0.0451	CbGbCtD
Halofantrine—CYP3A4—Toremifene—breast cancer	0.0196	0.0413	CbGbCtD
Halofantrine—CYP3A5—Tamoxifen—breast cancer	0.0184	0.0387	CbGbCtD
Halofantrine—CYP3A4—Fulvestrant—breast cancer	0.0182	0.0384	CbGbCtD
Halofantrine—CYP2C8—Tamoxifen—breast cancer	0.0177	0.0372	CbGbCtD
Halofantrine—CYP3A4—Thiotepa—breast cancer	0.0162	0.0342	CbGbCtD
Halofantrine—CYP3A4—Ixabepilone—breast cancer	0.0149	0.0313	CbGbCtD
Halofantrine—CYP3A4—Lapatinib—breast cancer	0.0143	0.0301	CbGbCtD
Halofantrine—CYP3A5—Paclitaxel—breast cancer	0.0143	0.0301	CbGbCtD
Halofantrine—CYP3A5—Irinotecan—breast cancer	0.0141	0.0297	CbGbCtD
Halofantrine—CYP2C8—Paclitaxel—breast cancer	0.0137	0.0289	CbGbCtD
Halofantrine—CYP2C8—Fluorouracil—breast cancer	0.013	0.0274	CbGbCtD
Halofantrine—CYP2D6—Vinorelbine—breast cancer	0.0125	0.0263	CbGbCtD
Halofantrine—CYP2D6—Tamoxifen—breast cancer	0.0113	0.0237	CbGbCtD
Halofantrine—CYP3A4—Raloxifene—breast cancer	0.0108	0.0228	CbGbCtD
Halofantrine—CYP3A5—Docetaxel—breast cancer	0.0103	0.0218	CbGbCtD
Halofantrine—CYP3A4—Vinorelbine—breast cancer	0.00793	0.0167	CbGbCtD
Halofantrine—CYP2D6—Vinblastine—breast cancer	0.00769	0.0162	CbGbCtD
Halofantrine—CYP3A4—Tamoxifen—breast cancer	0.00716	0.0151	CbGbCtD
Halofantrine—CYP3A4—Mitoxantrone—breast cancer	0.00698	0.0147	CbGbCtD
Halofantrine—CYP3A4—Paclitaxel—breast cancer	0.00557	0.0117	CbGbCtD
Halofantrine—CYP3A4—Irinotecan—breast cancer	0.0055	0.0116	CbGbCtD
Halofantrine—CYP3A4—Vinblastine—breast cancer	0.00489	0.0103	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—breast cancer	0.00472	0.00995	CbGbCtD
Halofantrine—CYP3A4—Docetaxel—breast cancer	0.00403	0.00848	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—breast cancer	0.003	0.00632	CbGbCtD
Halofantrine—Lumefantrine—CYP2D6—breast cancer	0.00188	0.538	CrCbGaD
Halofantrine—Lumefantrine—CYP3A4—breast cancer	0.00162	0.462	CrCbGaD
Halofantrine—Abdominal distension—Epirubicin—breast cancer	0.000118	0.000813	CcSEcCtD
Halofantrine—Nausea—Melphalan—breast cancer	0.000118	0.000812	CcSEcCtD
Halofantrine—Feeling abnormal—Mitoxantrone—breast cancer	0.000118	0.000812	CcSEcCtD
Halofantrine—Feeling abnormal—Irinotecan—breast cancer	0.000118	0.000812	CcSEcCtD
Halofantrine—Confusional state—Paclitaxel—breast cancer	0.000117	0.00081	CcSEcCtD
Halofantrine—Back pain—Docetaxel—breast cancer	0.000117	0.000807	CcSEcCtD
Halofantrine—Pruritus—Thiotepa—breast cancer	0.000117	0.000807	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000117	0.000806	CcSEcCtD
Halofantrine—Gastrointestinal pain—Irinotecan—breast cancer	0.000117	0.000806	CcSEcCtD
Halofantrine—Anaphylactic shock—Paclitaxel—breast cancer	0.000116	0.000803	CcSEcCtD
Halofantrine—Nausea—Goserelin—breast cancer	0.000115	0.000792	CcSEcCtD
Halofantrine—Feeling abnormal—Gemcitabine—breast cancer	0.000114	0.000791	CcSEcCtD
Halofantrine—Dizziness—Vinorelbine—breast cancer	0.000114	0.00079	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—breast cancer	0.000114	0.00079	CcSEcCtD
Halofantrine—Urticaria—Mitoxantrone—breast cancer	0.000113	0.000783	CcSEcCtD
Halofantrine—Back pain—Capecitabine—breast cancer	0.000113	0.000781	CcSEcCtD
Halofantrine—Diarrhoea—Thiotepa—breast cancer	0.000113	0.00078	CcSEcCtD
Halofantrine—Abdominal pain—Irinotecan—breast cancer	0.000113	0.000779	CcSEcCtD
Halofantrine—Abdominal pain—Mitoxantrone—breast cancer	0.000113	0.000779	CcSEcCtD
Halofantrine—Feeling abnormal—Fluorouracil—breast cancer	0.000113	0.000777	CcSEcCtD
Halofantrine—Anorexia—Paclitaxel—breast cancer	0.000111	0.000766	CcSEcCtD
Halofantrine—Vomiting—Vinorelbine—breast cancer	0.00011	0.000759	CcSEcCtD
Halofantrine—Dizziness—Thiotepa—breast cancer	0.000109	0.000754	CcSEcCtD
Halofantrine—Rash—Vinorelbine—breast cancer	0.000109	0.000753	CcSEcCtD
Halofantrine—Dermatitis—Vinorelbine—breast cancer	0.000109	0.000752	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—breast cancer	0.000109	0.000752	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—breast cancer	0.000109	0.00075	CcSEcCtD
Halofantrine—Ill-defined disorder—Capecitabine—breast cancer	0.000109	0.00075	CcSEcCtD
Halofantrine—Urticaria—Fluorouracil—breast cancer	0.000109	0.00075	CcSEcCtD
Halofantrine—Headache—Vinorelbine—breast cancer	0.000108	0.000748	CcSEcCtD
Halofantrine—Pollakiuria—Epirubicin—breast cancer	0.000108	0.000746	CcSEcCtD
Halofantrine—Palpitations—Docetaxel—breast cancer	0.000107	0.000737	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000106	0.000732	CcSEcCtD
Halofantrine—Malaise—Capecitabine—breast cancer	0.000105	0.000729	CcSEcCtD
Halofantrine—Cough—Docetaxel—breast cancer	0.000105	0.000728	CcSEcCtD
Halofantrine—Vomiting—Thiotepa—breast cancer	0.000105	0.000725	CcSEcCtD
Halofantrine—Convulsion—Docetaxel—breast cancer	0.000105	0.000723	CcSEcCtD
Halofantrine—Paraesthesia—Paclitaxel—breast cancer	0.000104	0.000721	CcSEcCtD
Halofantrine—Rash—Thiotepa—breast cancer	0.000104	0.000719	CcSEcCtD
Halofantrine—Dermatitis—Thiotepa—breast cancer	0.000104	0.000719	CcSEcCtD
Halofantrine—Headache—Thiotepa—breast cancer	0.000103	0.000715	CcSEcCtD
Halofantrine—Palpitations—Capecitabine—breast cancer	0.000103	0.000714	CcSEcCtD
Halofantrine—Chest pain—Docetaxel—breast cancer	0.000103	0.00071	CcSEcCtD
Halofantrine—Arthralgia—Docetaxel—breast cancer	0.000103	0.00071	CcSEcCtD
Halofantrine—Myalgia—Docetaxel—breast cancer	0.000103	0.00071	CcSEcCtD
Halofantrine—Nausea—Vinorelbine—breast cancer	0.000103	0.000709	CcSEcCtD
Halofantrine—Dyspepsia—Paclitaxel—breast cancer	0.000102	0.000707	CcSEcCtD
Halofantrine—Asthenia—Irinotecan—breast cancer	0.000102	0.000707	CcSEcCtD
Halofantrine—Asthenia—Mitoxantrone—breast cancer	0.000102	0.000707	CcSEcCtD
Halofantrine—Cough—Capecitabine—breast cancer	0.000102	0.000705	CcSEcCtD
Halofantrine—Stomatitis—Epirubicin—breast cancer	0.000102	0.000702	CcSEcCtD
Halofantrine—Decreased appetite—Paclitaxel—breast cancer	0.000101	0.000698	CcSEcCtD
Halofantrine—Fatigue—Paclitaxel—breast cancer	0.0001	0.000693	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—breast cancer	9.99e-05	0.00069	CcSEcCtD
Halofantrine—Asthenia—Gemcitabine—breast cancer	9.97e-05	0.000688	CcSEcCtD
Halofantrine—Myalgia—Capecitabine—breast cancer	9.96e-05	0.000688	CcSEcCtD
Halofantrine—Chest pain—Capecitabine—breast cancer	9.96e-05	0.000688	CcSEcCtD
Halofantrine—Arthralgia—Capecitabine—breast cancer	9.96e-05	0.000688	CcSEcCtD
Halofantrine—Constipation—Paclitaxel—breast cancer	9.95e-05	0.000687	CcSEcCtD
Halofantrine—Confusional state—Docetaxel—breast cancer	9.94e-05	0.000687	CcSEcCtD
Halofantrine—Anaphylactic shock—Docetaxel—breast cancer	9.86e-05	0.000681	CcSEcCtD
Halofantrine—Discomfort—Capecitabine—breast cancer	9.84e-05	0.00068	CcSEcCtD
Halofantrine—Pruritus—Gemcitabine—breast cancer	9.83e-05	0.000679	CcSEcCtD
Halofantrine—Nausea—Thiotepa—breast cancer	9.81e-05	0.000678	CcSEcCtD
Halofantrine—Diarrhoea—Irinotecan—breast cancer	9.76e-05	0.000674	CcSEcCtD
Halofantrine—Diarrhoea—Mitoxantrone—breast cancer	9.76e-05	0.000674	CcSEcCtD
Halofantrine—Pruritus—Fluorouracil—breast cancer	9.66e-05	0.000668	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—breast cancer	9.64e-05	0.000666	CcSEcCtD
Halofantrine—Confusional state—Capecitabine—breast cancer	9.62e-05	0.000665	CcSEcCtD
Halofantrine—Feeling abnormal—Paclitaxel—breast cancer	9.58e-05	0.000662	CcSEcCtD
Halofantrine—Gastrointestinal pain—Paclitaxel—breast cancer	9.51e-05	0.000657	CcSEcCtD
Halofantrine—Diarrhoea—Gemcitabine—breast cancer	9.51e-05	0.000657	CcSEcCtD
Halofantrine—Dizziness—Irinotecan—breast cancer	9.43e-05	0.000651	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—breast cancer	9.4e-05	0.00065	CcSEcCtD
Halofantrine—Anorexia—Docetaxel—breast cancer	9.4e-05	0.000649	CcSEcCtD
Halofantrine—Diarrhoea—Fluorouracil—breast cancer	9.35e-05	0.000646	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—breast cancer	9.32e-05	0.000644	CcSEcCtD
Halofantrine—Urticaria—Paclitaxel—breast cancer	9.24e-05	0.000638	CcSEcCtD
Halofantrine—Abdominal pain—Paclitaxel—breast cancer	9.19e-05	0.000635	CcSEcCtD
Halofantrine—Anorexia—Capecitabine—breast cancer	9.1e-05	0.000628	CcSEcCtD
Halofantrine—Vomiting—Mitoxantrone—breast cancer	9.07e-05	0.000626	CcSEcCtD
Halofantrine—Vomiting—Irinotecan—breast cancer	9.07e-05	0.000626	CcSEcCtD
Halofantrine—Dizziness—Fluorouracil—breast cancer	9.03e-05	0.000624	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—breast cancer	9.02e-05	0.000623	CcSEcCtD
Halofantrine—Rash—Mitoxantrone—breast cancer	8.99e-05	0.000621	CcSEcCtD
Halofantrine—Rash—Irinotecan—breast cancer	8.99e-05	0.000621	CcSEcCtD
Halofantrine—Dermatitis—Irinotecan—breast cancer	8.98e-05	0.000621	CcSEcCtD
Halofantrine—Dermatitis—Mitoxantrone—breast cancer	8.98e-05	0.000621	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Docetaxel—breast cancer	8.98e-05	0.00062	CcSEcCtD
Halofantrine—Chills—Methotrexate—breast cancer	8.97e-05	0.00062	CcSEcCtD
Halofantrine—Headache—Mitoxantrone—breast cancer	8.93e-05	0.000617	CcSEcCtD
Halofantrine—Headache—Irinotecan—breast cancer	8.93e-05	0.000617	CcSEcCtD
Halofantrine—Paraesthesia—Docetaxel—breast cancer	8.85e-05	0.000611	CcSEcCtD
Halofantrine—Vomiting—Gemcitabine—breast cancer	8.83e-05	0.00061	CcSEcCtD
Halofantrine—Rash—Gemcitabine—breast cancer	8.76e-05	0.000605	CcSEcCtD
Halofantrine—Dermatitis—Gemcitabine—breast cancer	8.75e-05	0.000604	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—breast cancer	8.73e-05	0.000603	CcSEcCtD
Halofantrine—Headache—Gemcitabine—breast cancer	8.7e-05	0.000601	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Capecitabine—breast cancer	8.7e-05	0.000601	CcSEcCtD
Halofantrine—Vomiting—Fluorouracil—breast cancer	8.68e-05	0.0006	CcSEcCtD
Halofantrine—Dyspepsia—Docetaxel—breast cancer	8.68e-05	0.000599	CcSEcCtD
Halofantrine—Rash—Fluorouracil—breast cancer	8.61e-05	0.000595	CcSEcCtD
Halofantrine—Dermatitis—Fluorouracil—breast cancer	8.6e-05	0.000594	CcSEcCtD
Halofantrine—Paraesthesia—Capecitabine—breast cancer	8.57e-05	0.000592	CcSEcCtD
Halofantrine—Decreased appetite—Docetaxel—breast cancer	8.57e-05	0.000592	CcSEcCtD
Halofantrine—Headache—Fluorouracil—breast cancer	8.56e-05	0.000591	CcSEcCtD
Halofantrine—Fatigue—Docetaxel—breast cancer	8.5e-05	0.000587	CcSEcCtD
Halofantrine—Nausea—Mitoxantrone—breast cancer	8.47e-05	0.000585	CcSEcCtD
Halofantrine—Nausea—Irinotecan—breast cancer	8.47e-05	0.000585	CcSEcCtD
Halofantrine—Constipation—Docetaxel—breast cancer	8.43e-05	0.000582	CcSEcCtD
Halofantrine—Back pain—Methotrexate—breast cancer	8.42e-05	0.000582	CcSEcCtD
Halofantrine—Dyspepsia—Capecitabine—breast cancer	8.4e-05	0.00058	CcSEcCtD
Halofantrine—Chills—Epirubicin—breast cancer	8.4e-05	0.00058	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—breast cancer	8.36e-05	0.000578	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—breast cancer	8.35e-05	0.000576	CcSEcCtD
Halofantrine—Asthenia—Paclitaxel—breast cancer	8.34e-05	0.000576	CcSEcCtD
Halofantrine—Decreased appetite—Capecitabine—breast cancer	8.3e-05	0.000573	CcSEcCtD
Halofantrine—Nausea—Gemcitabine—breast cancer	8.25e-05	0.00057	CcSEcCtD
Halofantrine—Fatigue—Capecitabine—breast cancer	8.23e-05	0.000568	CcSEcCtD
Halofantrine—Pruritus—Paclitaxel—breast cancer	8.23e-05	0.000568	CcSEcCtD
Halofantrine—Constipation—Capecitabine—breast cancer	8.16e-05	0.000564	CcSEcCtD
Halofantrine—Feeling abnormal—Docetaxel—breast cancer	8.12e-05	0.000561	CcSEcCtD
Halofantrine—Nausea—Fluorouracil—breast cancer	8.11e-05	0.00056	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—breast cancer	8.08e-05	0.000558	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—breast cancer	8.07e-05	0.000558	CcSEcCtD
Halofantrine—Gastrointestinal pain—Docetaxel—breast cancer	8.06e-05	0.000557	CcSEcCtD
Halofantrine—Diarrhoea—Paclitaxel—breast cancer	7.96e-05	0.00055	CcSEcCtD
Halofantrine—Back pain—Epirubicin—breast cancer	7.88e-05	0.000544	CcSEcCtD
Halofantrine—Feeling abnormal—Capecitabine—breast cancer	7.87e-05	0.000543	CcSEcCtD
Halofantrine—Malaise—Methotrexate—breast cancer	7.85e-05	0.000542	CcSEcCtD
Halofantrine—Gastrointestinal pain—Capecitabine—breast cancer	7.81e-05	0.000539	CcSEcCtD
Halofantrine—Abdominal pain—Docetaxel—breast cancer	7.79e-05	0.000538	CcSEcCtD
Halofantrine—Chills—Doxorubicin—breast cancer	7.77e-05	0.000537	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—breast cancer	7.74e-05	0.000534	CcSEcCtD
Halofantrine—Dizziness—Paclitaxel—breast cancer	7.69e-05	0.000531	CcSEcCtD
Halofantrine—Cough—Methotrexate—breast cancer	7.6e-05	0.000525	CcSEcCtD
Halofantrine—Urticaria—Capecitabine—breast cancer	7.58e-05	0.000524	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—breast cancer	7.56e-05	0.000522	CcSEcCtD
Halofantrine—Abdominal pain—Capecitabine—breast cancer	7.55e-05	0.000521	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—breast cancer	7.54e-05	0.000521	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—breast cancer	7.41e-05	0.000512	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—breast cancer	7.41e-05	0.000512	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—breast cancer	7.41e-05	0.000512	CcSEcCtD
Halofantrine—Vomiting—Paclitaxel—breast cancer	7.4e-05	0.000511	CcSEcCtD
Halofantrine—Malaise—Epirubicin—breast cancer	7.35e-05	0.000508	CcSEcCtD
Halofantrine—Rash—Paclitaxel—breast cancer	7.33e-05	0.000507	CcSEcCtD
Halofantrine—Dermatitis—Paclitaxel—breast cancer	7.33e-05	0.000506	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—breast cancer	7.32e-05	0.000506	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—breast cancer	7.29e-05	0.000504	CcSEcCtD
Halofantrine—Headache—Paclitaxel—breast cancer	7.29e-05	0.000503	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—breast cancer	7.2e-05	0.000497	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—breast cancer	7.16e-05	0.000495	CcSEcCtD
Halofantrine—Cough—Epirubicin—breast cancer	7.11e-05	0.000491	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—breast cancer	7.11e-05	0.000491	CcSEcCtD
Halofantrine—Asthenia—Docetaxel—breast cancer	7.07e-05	0.000489	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—breast cancer	7.06e-05	0.000488	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—breast cancer	6.99e-05	0.000483	CcSEcCtD
Halofantrine—Pruritus—Docetaxel—breast cancer	6.97e-05	0.000482	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—breast cancer	6.94e-05	0.000479	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—breast cancer	6.94e-05	0.000479	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—breast cancer	6.94e-05	0.000479	CcSEcCtD
Halofantrine—Nausea—Paclitaxel—breast cancer	6.91e-05	0.000477	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—breast cancer	6.85e-05	0.000473	CcSEcCtD
Halofantrine—Asthenia—Capecitabine—breast cancer	6.85e-05	0.000473	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—breast cancer	6.8e-05	0.00047	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—breast cancer	6.77e-05	0.000468	CcSEcCtD
Halofantrine—Pruritus—Capecitabine—breast cancer	6.75e-05	0.000466	CcSEcCtD
Halofantrine—Diarrhoea—Docetaxel—breast cancer	6.75e-05	0.000466	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—breast cancer	6.7e-05	0.000463	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—breast cancer	6.66e-05	0.00046	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—breast cancer	6.65e-05	0.000459	CcSEcCtD
Halofantrine—Cough—Doxorubicin—breast cancer	6.58e-05	0.000454	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—breast cancer	6.53e-05	0.000451	CcSEcCtD
Halofantrine—Diarrhoea—Capecitabine—breast cancer	6.53e-05	0.000451	CcSEcCtD
Halofantrine—Dizziness—Docetaxel—breast cancer	6.52e-05	0.00045	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—breast cancer	6.47e-05	0.000447	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—breast cancer	6.42e-05	0.000443	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—breast cancer	6.42e-05	0.000443	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—breast cancer	6.42e-05	0.000443	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—breast cancer	6.38e-05	0.000441	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—breast cancer	6.34e-05	0.000438	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—breast cancer	6.34e-05	0.000438	CcSEcCtD
Halofantrine—Dizziness—Capecitabine—breast cancer	6.31e-05	0.000436	CcSEcCtD
Halofantrine—Vomiting—Docetaxel—breast cancer	6.27e-05	0.000433	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—breast cancer	6.25e-05	0.000432	CcSEcCtD
Halofantrine—Rash—Docetaxel—breast cancer	6.22e-05	0.000429	CcSEcCtD
Halofantrine—Dermatitis—Docetaxel—breast cancer	6.21e-05	0.000429	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—breast cancer	6.2e-05	0.000429	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—breast cancer	6.18e-05	0.000427	CcSEcCtD
Halofantrine—Headache—Docetaxel—breast cancer	6.18e-05	0.000427	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—breast cancer	6.15e-05	0.000425	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—breast cancer	6.13e-05	0.000423	CcSEcCtD
Halofantrine—Vomiting—Capecitabine—breast cancer	6.07e-05	0.000419	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—breast cancer	6.06e-05	0.000418	CcSEcCtD
Halofantrine—Rash—Capecitabine—breast cancer	6.02e-05	0.000416	CcSEcCtD
Halofantrine—Dermatitis—Capecitabine—breast cancer	6.01e-05	0.000415	CcSEcCtD
Halofantrine—Headache—Capecitabine—breast cancer	5.98e-05	0.000413	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—breast cancer	5.97e-05	0.000412	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—breast cancer	5.86e-05	0.000405	CcSEcCtD
Halofantrine—Nausea—Docetaxel—breast cancer	5.86e-05	0.000404	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—breast cancer	5.86e-05	0.000404	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—breast cancer	5.85e-05	0.000404	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—breast cancer	5.81e-05	0.000401	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—breast cancer	5.78e-05	0.000399	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—breast cancer	5.73e-05	0.000396	CcSEcCtD
Halofantrine—Constipation—Epirubicin—breast cancer	5.69e-05	0.000393	CcSEcCtD
Halofantrine—Nausea—Capecitabine—breast cancer	5.67e-05	0.000392	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—breast cancer	5.64e-05	0.00039	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—breast cancer	5.62e-05	0.000388	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.61e-05	0.000387	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—breast cancer	5.52e-05	0.000382	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—breast cancer	5.48e-05	0.000378	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—breast cancer	5.44e-05	0.000376	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—breast cancer	5.42e-05	0.000374	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—breast cancer	5.35e-05	0.000369	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—breast cancer	5.3e-05	0.000366	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—breast cancer	5.28e-05	0.000365	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—breast cancer	5.26e-05	0.000363	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—breast cancer	5.26e-05	0.000363	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—breast cancer	5.1e-05	0.000352	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—breast cancer	5.07e-05	0.00035	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—breast cancer	5.03e-05	0.000348	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—breast cancer	5.03e-05	0.000347	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—breast cancer	4.89e-05	0.000338	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—breast cancer	4.86e-05	0.000336	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—breast cancer	4.86e-05	0.000336	CcSEcCtD
Halofantrine—Asthenia—Epirubicin—breast cancer	4.77e-05	0.00033	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—breast cancer	4.7e-05	0.000325	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—breast cancer	4.7e-05	0.000325	CcSEcCtD
Halofantrine—Diarrhoea—Epirubicin—breast cancer	4.55e-05	0.000314	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—breast cancer	4.52e-05	0.000312	CcSEcCtD
Halofantrine—Rash—Methotrexate—breast cancer	4.48e-05	0.000309	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—breast cancer	4.48e-05	0.000309	CcSEcCtD
Halofantrine—Headache—Methotrexate—breast cancer	4.45e-05	0.000307	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—breast cancer	4.41e-05	0.000305	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—breast cancer	4.4e-05	0.000304	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—breast cancer	4.35e-05	0.000301	CcSEcCtD
Halofantrine—Vomiting—Epirubicin—breast cancer	4.23e-05	0.000292	CcSEcCtD
Halofantrine—Nausea—Methotrexate—breast cancer	4.22e-05	0.000292	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—breast cancer	4.21e-05	0.000291	CcSEcCtD
Halofantrine—Rash—Epirubicin—breast cancer	4.19e-05	0.00029	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—breast cancer	4.19e-05	0.000289	CcSEcCtD
Halofantrine—Headache—Epirubicin—breast cancer	4.17e-05	0.000288	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—breast cancer	4.07e-05	0.000281	CcSEcCtD
Halofantrine—Nausea—Epirubicin—breast cancer	3.95e-05	0.000273	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—breast cancer	3.91e-05	0.00027	CcSEcCtD
Halofantrine—Rash—Doxorubicin—breast cancer	3.88e-05	0.000268	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—breast cancer	3.88e-05	0.000268	CcSEcCtD
Halofantrine—Headache—Doxorubicin—breast cancer	3.85e-05	0.000266	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—breast cancer	3.65e-05	0.000252	CcSEcCtD
Halofantrine—CYP2D6—Metabolism—HMMR—breast cancer	1.02e-05	0.000206	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCC1—breast cancer	1.02e-05	0.000206	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC2A2—breast cancer	1.01e-05	0.000205	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTR—breast cancer	9.91e-06	0.000201	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CPT1A—breast cancer	9.91e-06	0.000201	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCG2—breast cancer	9.91e-06	0.000201	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARGC1B—breast cancer	9.84e-06	0.0002	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HPGDS—breast cancer	9.72e-06	0.000197	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HBA1—breast cancer	9.66e-06	0.000196	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.52e-06	0.000193	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CDA—breast cancer	9.43e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SHMT1—breast cancer	9.43e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTT1—breast cancer	9.42e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ACHE—breast cancer	9.42e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA4—breast cancer	9.3e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CA9—breast cancer	9.3e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MED12—breast cancer	9.23e-06	0.000187	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—DPYD—breast cancer	9.23e-06	0.000187	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALDOA—breast cancer	9.09e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A5—breast cancer	9.08e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.08e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA2—breast cancer	9.06e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GPX2—breast cancer	9.06e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GPX4—breast cancer	8.95e-06	0.000181	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SULT1A1—breast cancer	8.95e-06	0.000181	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP17A1—breast cancer	8.92e-06	0.000181	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS1—breast cancer	8.83e-06	0.000179	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ENO1—breast cancer	8.83e-06	0.000179	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOA3—breast cancer	8.82e-06	0.000179	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APRT—breast cancer	8.77e-06	0.000178	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC2A2—breast cancer	8.76e-06	0.000178	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—IDH1—breast cancer	8.74e-06	0.000177	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA1—breast cancer	8.74e-06	0.000177	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.67e-06	0.000176	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2D6—breast cancer	8.66e-06	0.000176	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NAT2—breast cancer	8.64e-06	0.000175	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCG2—breast cancer	8.58e-06	0.000174	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTR—breast cancer	8.58e-06	0.000174	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CPT1A—breast cancer	8.58e-06	0.000174	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOA2—breast cancer	8.5e-06	0.000172	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HPGDS—breast cancer	8.42e-06	0.000171	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HBA1—breast cancer	8.36e-06	0.00017	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ESRRA—breast cancer	8.24e-06	0.000167	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.24e-06	0.000167	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—FASN—breast cancer	8.24e-06	0.000167	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—BCHE—breast cancer	8.21e-06	0.000166	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTT1—breast cancer	8.16e-06	0.000165	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ACHE—breast cancer	8.16e-06	0.000165	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC5A5—breast cancer	8.11e-06	0.000164	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC2A1—breast cancer	7.83e-06	0.000159	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NQO1—breast cancer	7.83e-06	0.000159	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPI—breast cancer	7.82e-06	0.000158	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HADHB—breast cancer	7.82e-06	0.000158	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP17A1—breast cancer	7.73e-06	0.000157	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ENO1—breast cancer	7.65e-06	0.000155	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS1—breast cancer	7.65e-06	0.000155	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP3A4—breast cancer	7.64e-06	0.000155	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.62e-06	0.000154	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—DPYD—breast cancer	7.58e-06	0.000154	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MED12—breast cancer	7.58e-06	0.000154	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.52e-06	0.000152	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP1B1—breast cancer	7.51e-06	0.000152	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2D6—breast cancer	7.5e-06	0.000152	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALDOA—breast cancer	7.46e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.46e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.46e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HSP90AA1—breast cancer	7.36e-06	0.000149	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOA2—breast cancer	7.36e-06	0.000149	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOA3—breast cancer	7.24e-06	0.000147	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC2A2—breast cancer	7.19e-06	0.000146	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOA1—breast cancer	7.16e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—UMPS—breast cancer	7.15e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ADSL—breast cancer	7.15e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PHGDH—breast cancer	7.15e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—FHL2—breast cancer	7.15e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NME1—breast cancer	7.15e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—FASN—breast cancer	7.14e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—BCHE—breast cancer	7.11e-06	0.000144	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—STK11—breast cancer	7.06e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP19A1—breast cancer	7.06e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CPT1A—breast cancer	7.05e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTR—breast cancer	7.05e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCG2—breast cancer	7.05e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC5A5—breast cancer	7.02e-06	0.000142	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LDHB—breast cancer	7.01e-06	0.000142	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—BRIP1—breast cancer	7.01e-06	0.000142	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HPSE—breast cancer	7.01e-06	0.000142	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HPGDS—breast cancer	6.91e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HBA1—breast cancer	6.87e-06	0.000139	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NQO1—breast cancer	6.78e-06	0.000137	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC2A1—breast cancer	6.78e-06	0.000137	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ACHE—breast cancer	6.7e-06	0.000136	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTT1—breast cancer	6.7e-06	0.000136	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCC1—breast cancer	6.65e-06	0.000135	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMMR—breast cancer	6.65e-06	0.000135	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA3—breast cancer	6.65e-06	0.000135	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.64e-06	0.000135	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP3A4—breast cancer	6.62e-06	0.000134	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.58e-06	0.000133	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—COMT—breast cancer	6.56e-06	0.000133	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTP1—breast cancer	6.53e-06	0.000132	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP1B1—breast cancer	6.5e-06	0.000132	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMOX1—breast cancer	6.44e-06	0.000131	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.44e-06	0.00013	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ITPR1—breast cancer	6.43e-06	0.00013	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSP90AA1—breast cancer	6.38e-06	0.000129	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP17A1—breast cancer	6.34e-06	0.000129	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS1—breast cancer	6.28e-06	0.000127	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ENO1—breast cancer	6.28e-06	0.000127	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOA1—breast cancer	6.2e-06	0.000126	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCB1—breast cancer	6.18e-06	0.000125	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—STK11—breast cancer	6.12e-06	0.000124	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP19A1—breast cancer	6.12e-06	0.000124	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CA9—breast cancer	6.08e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA4—breast cancer	6.08e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TYMS—breast cancer	6.07e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOA2—breast cancer	6.05e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLA2G4A—breast cancer	6e-06	0.000122	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOR1—breast cancer	6e-06	0.000122	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM1—breast cancer	6e-06	0.000122	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA2—breast cancer	5.92e-06	0.00012	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPX2—breast cancer	5.92e-06	0.00012	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—FASN—breast cancer	5.86e-06	0.000119	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPX4—breast cancer	5.85e-06	0.000119	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SULT1A1—breast cancer	5.85e-06	0.000119	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—BCHE—breast cancer	5.84e-06	0.000118	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC5A5—breast cancer	5.77e-06	0.000117	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GPX1—breast cancer	5.75e-06	0.000117	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.74e-06	0.000116	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA1—breast cancer	5.71e-06	0.000116	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—IDH1—breast cancer	5.71e-06	0.000116	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP1A1—breast cancer	5.69e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—COMT—breast cancer	5.69e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTP1—breast cancer	5.66e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NAT2—breast cancer	5.65e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ERCC2—breast cancer	5.64e-06	0.000114	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMOX1—breast cancer	5.58e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NQO1—breast cancer	5.57e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC2A1—breast cancer	5.57e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ITPR1—breast cancer	5.57e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP3A4—breast cancer	5.43e-06	0.00011	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCB1—breast cancer	5.36e-06	0.000109	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP1B1—breast cancer	5.34e-06	0.000108	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—breast cancer	5.31e-06	0.000108	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TYMS—breast cancer	5.26e-06	0.000107	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.24e-06	0.000106	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM1—breast cancer	5.2e-06	0.000105	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOR1—breast cancer	5.2e-06	0.000105	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLA2G4A—breast cancer	5.2e-06	0.000105	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOA1—breast cancer	5.09e-06	0.000103	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—STK11—breast cancer	5.02e-06	0.000102	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP19A1—breast cancer	5.02e-06	0.000102	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GPX1—breast cancer	4.98e-06	0.000101	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—DPYD—breast cancer	4.96e-06	0.0001	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MED12—breast cancer	4.96e-06	0.0001	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP1A1—breast cancer	4.93e-06	9.99e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CAV1—breast cancer	4.89e-06	9.92e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ERCC2—breast cancer	4.89e-06	9.91e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALDOA—breast cancer	4.88e-06	9.89e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOA3—breast cancer	4.74e-06	9.6e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A2—breast cancer	4.7e-06	9.53e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—COMT—breast cancer	4.67e-06	9.46e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTP1—breast cancer	4.65e-06	9.41e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTR—breast cancer	4.61e-06	9.34e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CPT1A—breast cancer	4.61e-06	9.34e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCG2—breast cancer	4.61e-06	9.34e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—breast cancer	4.6e-06	9.31e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMOX1—breast cancer	4.58e-06	9.29e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ITPR1—breast cancer	4.57e-06	9.26e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HPGDS—breast cancer	4.52e-06	9.16e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HBA1—breast cancer	4.49e-06	9.1e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CG—breast cancer	4.46e-06	9.03e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCB1—breast cancer	4.4e-06	8.91e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ACHE—breast cancer	4.38e-06	8.88e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTT1—breast cancer	4.38e-06	8.88e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TYMS—breast cancer	4.32e-06	8.75e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.27e-06	8.65e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM1—breast cancer	4.27e-06	8.65e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOR1—breast cancer	4.27e-06	8.65e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CAV1—breast cancer	4.24e-06	8.59e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.15e-06	8.41e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS1—breast cancer	4.11e-06	8.32e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ENO1—breast cancer	4.11e-06	8.32e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GPX1—breast cancer	4.09e-06	8.29e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.05e-06	8.21e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP1A1—breast cancer	4.05e-06	8.2e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.03e-06	8.16e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ERCC2—breast cancer	4.01e-06	8.13e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOA2—breast cancer	3.95e-06	8.01e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CD—breast cancer	3.92e-06	7.94e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALB—breast cancer	3.87e-06	7.84e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CG—breast cancer	3.86e-06	7.83e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—FASN—breast cancer	3.83e-06	7.77e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—BCHE—breast cancer	3.82e-06	7.74e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—breast cancer	3.77e-06	7.65e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.77e-06	7.64e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NOS3—breast cancer	3.7e-06	7.5e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.64e-06	7.38e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NQO1—breast cancer	3.64e-06	7.38e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.49e-06	7.08e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CAV1—breast cancer	3.48e-06	7.05e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.42e-06	6.94e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CB—breast cancer	3.42e-06	6.92e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CD—breast cancer	3.39e-06	6.88e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS2—breast cancer	3.38e-06	6.86e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALB—breast cancer	3.35e-06	6.79e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOA1—breast cancer	3.33e-06	6.75e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.28e-06	6.65e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—STK11—breast cancer	3.28e-06	6.65e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NOS3—breast cancer	3.21e-06	6.5e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.17e-06	6.42e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—COMT—breast cancer	3.05e-06	6.18e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTP1—breast cancer	3.04e-06	6.16e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMOX1—breast cancer	3e-06	6.07e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ITPR1—breast cancer	2.99e-06	6.06e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CB—breast cancer	2.96e-06	6e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTEN—breast cancer	2.95e-06	5.98e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS2—breast cancer	2.93e-06	5.94e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCB1—breast cancer	2.87e-06	5.83e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TYMS—breast cancer	2.82e-06	5.72e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.79e-06	5.66e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOR1—breast cancer	2.79e-06	5.66e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM1—breast cancer	2.79e-06	5.66e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.79e-06	5.65e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALB—breast cancer	2.75e-06	5.58e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPX1—breast cancer	2.67e-06	5.42e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.65e-06	5.36e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NOS3—breast cancer	2.63e-06	5.33e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ERCC2—breast cancer	2.62e-06	5.32e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTEN—breast cancer	2.56e-06	5.18e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—breast cancer	2.47e-06	5e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.43e-06	4.92e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS2—breast cancer	2.41e-06	4.88e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CAV1—breast cancer	2.28e-06	4.61e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTEN—breast cancer	2.1e-06	4.25e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CA—breast cancer	2.08e-06	4.22e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.07e-06	4.2e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.82e-06	3.69e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CA—breast cancer	1.8e-06	3.66e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALB—breast cancer	1.8e-06	3.65e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NOS3—breast cancer	1.72e-06	3.49e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—breast cancer	1.7e-06	3.45e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.59e-06	3.22e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS2—breast cancer	1.57e-06	3.19e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.48e-06	3e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—breast cancer	1.47e-06	2.99e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTEN—breast cancer	1.37e-06	2.78e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—breast cancer	1.21e-06	2.45e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CA—breast cancer	9.68e-07	1.96e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—breast cancer	7.91e-07	1.6e-05	CbGpPWpGaD
